Carlyle Group Inc has agreed to buy a 20% stake in the pharmaceutical unit of Indian conglomerate Piramal Enterprises Ltd for $490 million. Piramal Pharma will use the capital injection to accelerate its organic and inorganic growth plans. This transaction is one of the largest private equity deals in the Indian pharmaceutical...
Carlyle Invests $235 million in Indian Data Centers
The Carlyle Group based in Washington DC, is investing $235 million on buying a quarter of Nxtra, the data center subsidiary of India's Bharti Airtel. Nxtra has ten large data centers and 120 edge data centers in India. It hopes to use the investment to expand its presence and offerings in...
KKR's New Asia-Focused Fund Targets $15 Billion
Global private equity group KKR & Co Inc has targeted a record $15 billion for a new Asia-focused buyout fund. Groups such as Bain Capital, Blackstone, Carlyle, and KKR are increasingly focusing on Asian investments as lower valuations and corporate restructuring have created new opportunities in key markets. An Asian...
Carlyle's $1 Billion Growth Fund to Focus on India and China
Washington D.C.-based global private equity firm Carlyle will raise $1 billion under its new Asian growth fund largely focused on investing in India and China. Per a disclosure, the International Finance Corp is one of its Limited Partners, and the private sector investment arm of World Bank has committed $25...